A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Ditching Invading DNA: Bacteria and archaea protect themselves from invasive foreign nucleic acids through an RNA-mediated adaptive immune system called CRISPR (clustered regularly interspaced short palindromic repeats)/CRISPR-associated (Cas). Jinek et al. (p. 816 , published online 28 June; see the Perspective by Brouns ) found that for the type II CRISPR/Cas system, the CRISPR RNA (crRNA) as well as the trans-activating crRNA—which is known to be involved in the pre-crRNA processing—were both required to direct the Cas9 endonuclease to cleave the invading target DNA. Furthermore, engineered RNA molecules were able to program the Cas9 endonuclease to cleave specific DNA sequences to generate double-stranded DNA breaks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To realize this promise, the development of CRISPR-Cas9 for genome editing offers a simpler technology that has been adopted widely due to the ease of programming its DNA binding and modifying capabilities.”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombinant expression and purification of EvoCas9–1 paired with chemically synthesized Evo-generated single guide RNA (sgRNA) exhibited comparable in vitro cleavage activity to SpCas9 paired with the canonical SpCas9 sgRNA”
From Sequence modeling and design from molecular to genome scale with Evo (2024) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cas9 can create DNA cleavage at desired genomic positions that are guided by precise base pairing between sgRNA and DNA, adjacent to a protospacer-adjacent motif (PAM) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR/Cas9 is a class of ribonucleoprotein complexes formed by a Cas9 protein and a single guide RNA (sgRNA) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measured
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
Self-citationSmall CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Self-citationThe CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Christian, M., Cermak, T., Doyle, E. L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A. J., & Voytas, D. F. (2010) · Genetics · doi:10.1534/genetics.110.120717 · Cited by 1,869
Cited by
Items 501–600 of 1,285
Gene editing in plants: progress and challenges
Mao, Y., Botella, J. R., Liu, Y., & Zhu, J.-K. (2019) · National Science Review · doi:10.1093/nsr/nwz005 · Cited by 341
“The crRNA-tracrRNA duplex has been artificially fused into a chimeric single guide RNA (sgRNA) to direct DNA cleavage by the Cas9 protein [6].”
MethodCanver, M. C., Bauer, D. E., Dass, A., Yien, Y. Y., Chung, J., Masuda, T., Maeda, T., Paw, B. H., & Orkin, S. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.564625 · Cited by 345
A road map for understanding molecular and genetic determinants of osteoporosis
Yang, T.-L., Shen, H., Liu, A., Dong, S.-S., Zhang, L., Deng, F.-Y., Zhao, Q., & Deng, H.-W. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0282-7 · Cited by 341
Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum
Vinayak, S., Pawlowic, M. C., Sateriale, A., Brooks, C. F., Studstill, C. J., Bar-Peled, Y., Cipriano, M. J., & Striepen, B. (2015) · Nature · doi:10.1038/nature14651 · Cited by 349
CRISPR/Cas9-mediated targeted mutagenesis in Nicotiana tabacum
Gao, J., Wang, G., Ma, S., Xie, X., Wu, X., Zhang, X., Wu, Y., Zhao, P., & Xia, Q. (2015) · Plant Molecular Biology · doi:10.1007/s11103-014-0263-0 · Cited by 343
Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System
Altenbuchner, J. (2016) · Applied and Environmental Microbiology · doi:10.1128/aem.01453-16 · Cited by 335
Kinetic Basis for DNA Target Specificity of CRISPR-Cas12a
Strohkendl, I., Saifuddin, F. A., Rybarski, J. R., Finkelstein, I. J., & Russell, R. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.043 · Cited by 351
He, X., Tan, C., Wang, F., Wang, Y., Zhou, R., Cui, D., You, W., Zhao, H., Ren, J., & Feng, B. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw064 · Cited by 338
Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
Liao, H.-K., Gu, Y., Diaz, A., Marlett, J., Takahashi, Y., Li, M., Suzuki, K., Xu, R., Hishida, T., Chang, C.-J., et al. (2015) · Nature Communications · doi:10.1038/ncomms7413 · Cited by 336
How a fungus shapes biotechnology: 100 years of Aspergillus niger research
Cairns, T. C., Nai, C., & Meyer, V. (2018) · Fungal Biology and Biotechnology · doi:10.1186/s40694-018-0054-5 · Cited by 329
“In a seminal 2012 paper, it was shown that the system is programmable to cut any DNA sequence with high specificity [87], which generated a watershed momentum, given the ability of the endonuclease to retain its activity in many different organisms (fungi, insects, mice, humans, plants etc.”
BackgroundCRISPR-guided DNA polymerases enable diversification of all nucleotides in a tunable window
Halperin, S. O., Tou, C. J., Wong, E. B., Modavi, C., Schaffer, D. V., & Dueber, J. E. (2018) · Nature · doi:10.1038/s41586-018-0384-8 · Cited by 335
Integrase-mediated spacer acquisition during CRISPR–Cas adaptive immunity
Nuñez, J. K., Lee, A. S. Y., Engelman, A., & Doudna, J. A. (2015) · Nature · doi:10.1038/nature14237 · Cited by 347
Self-citationCRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications
Molla, K. A., & Yang, Y. (2019) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.03.008 · Cited by 331
CRISPR/Cas9 for cancer research and therapy
Zhan, T., Rindtorff, N., Betge, J., Ebert, M. P., & Boutros, M. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.04.001 · Cited by 328
CRISPR-Cas9 system: A new-fangled dawn in gene editing
Gupta, D., Bhattacharjee, O., Mandal, D., Sen, M. K., Dey, D., Dasgupta, A., Kazi, T. A., Gupta, R., Sinharoy, S., Acharya, K., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116636 · Cited by 323
Wang, X., Xiong, E., Tian, T., Cheng, M., Lin, W., Wang, H., Zhang, G., Sun, J., & Zhou, X. (2020) · ACS Nano · doi:10.1021/acsnano.0c00022 · Cited by 326
Epigenetic regulation of T cell exhaustion
Belk, J. A., Daniel, B., & Satpathy, A. T. (2022) · Nature Immunology · doi:10.1038/s41590-022-01224-z · Cited by 319
Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning
Wang, D., Zhang, C., Wang, B., Li, B., Wang, Q., Liu, D., Wang, H., Zhou, Y., Shi, L., Lan, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12281-8 · Cited by 331
Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes
Chen, S., Lee, B., Lee, A. Y.-F., Modzelewski, A. J., & He, L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.733154 · Cited by 333
mlo -Based Resistance: An Apparently Universal “Weapon” to Defeat Powdery Mildew Disease
Kusch, S., & Panstruga, R. (2017) · Molecular Plant-Microbe Interactions® · doi:10.1094/mpmi-12-16-0255-cr · Cited by 332
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells
Dong, M. B., Wang, G., Chow, R. D., Ye, L., Zhu, L., Dai, X., Park, J. J., Kim, H. R., Errami, Y., Guzman, C. D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.044 · Cited by 330
“CRISPR technologies have dramatically enhanced our ability in genome editing (Cong et al., 2013; Hsu et al., 2014; Jinek et al., 2012; Komor et al., 2017; Mali et al., 2013; Wright et al., 2016).”
Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing
Das, S., & Baker, A. B. (2016) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00082 · Cited by 330
“With the advent of CRISPR-Cas9 technology, it would be interesting to see how scientists apply this remarkable gene editing technology to engineer the wound microenvironment (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Mali et al., 2013; Sander and Joung, 2014).”
BackgroundHuntingtin Lowering Strategies for Disease Modification in Huntington’s Disease
Tabrizi, S. J., Ghosh, R., & Leavitt, B. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.039 · Cited by 337
Tagliabracci, V. S., Engel, J. L., Wiley, S. E., Xiao, J., Gonzalez, D. J., Nidumanda Appaiah, H., Koller, A., Nizet, V., White, K. E., & Dixon, J. E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402218111 · Cited by 327
Fonfara, I., Le Rhun, A., Chylinski, K., Makarova, K. S., Lécrivain, A.-L., Bzdrenga, J., Koonin, E. V., & Charpentier, E. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1074 · Cited by 328
“It was also shown before that in type II CRISPR-Cas, the PAM sequence is located in 30 of the protospacer, juxtaposed to the sequence targeted by cognate crRNA on the non-target strand (14,18,23,44).”
BackgroundInfluentialSelf-citationCRISPR/Cas9-mediated mutagenesis of the RIN locus that regulates tomato fruit ripening
Ito, Y., Nishizawa-Yokoi, A., Endo, M., Mikami, M., & Toki, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.117 · Cited by 322
A male-determining factor in the mosquito Aedes aegypti
Hall, A. B., Basu, S., Jiang, X., Qi, Y., Timoshevskiy, V. A., Biedler, J. K., Sharakhova, M. V., Elahi, R., Anderson, M. A. E., Chen, X.-G., et al. (2015) · Science · doi:10.1126/science.aaa2850 · Cited by 332
Schwartz, C. M., Hussain, M. S., Blenner, M., & Wheeldon, I. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00162 · Cited by 329
Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs
Firth, A. L., Menon, T., Parker, G. S., Qualls, S. J., Lewis, B. M., Ke, E., Dargitz, C. T., Wright, R., Khanna, A., Gage, F. H., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.062 · Cited by 326
Origins of Programmable Nucleases for Genome Engineering
Chandrasegaran, S., & Carroll, D. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.10.014 · Cited by 325
“In elegant work, Doudna, Charpentier and coworkers [99] showed that Cas9 endonuclease-mediated cleavage depends on tracrRNA and can also function efficiently using a fusion of crRNA and tracrRNA to form a single guide RNA (sgRNA), which greatly simplified the application of CRISPR-Cas9 system for genome engineering (F…”
InfluentialTherapeutic Oligonucleotides: State of the Art
Smith, C. I. E., & Zain, R. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021050 · Cited by 323
Efficient targeted DNA methylation with chimeric dCas9–Dnmt3a–Dnmt3L methyltransferase
Stepper, P., Kungulovski, G., Jurkowska, R. Z., Chandra, T., Krueger, F., Reinhardt, R., Reik, W., Jeltsch, A., & Jurkowski, T. P. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1112 · Cited by 324
“For commercial re-use, please contact journals.permissions@oup.com Nucleic Acids Research Advance Access published November 29, 2016 at B B SR C on D ecem ber 5, 2016 http://nar.oxfordjournals.org/ D ow nloaded from rial Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) (13) system and the nuclease-in…”
BackgroundInfluentialXie, K., Zhang, J., & Yang, Y. (2014) · Molecular Plant · doi:10.1093/mp/ssu009 · Cited by 331
“RNA-guided genome editing (RGE) using the Streptococcus pyogenes CRISPR-Cas9 system(Cong et al., 2013; Feng et al., 2013; Jiang et al., 2013b; Jinek et al., 2012; Mali et al., 2013b; Miao et al., 2013; Xie and Yang, 2013) is emerging as a simple and highly efficient tool for genome editing in many…”
MethodIdentifying and Visualizing Functional PAM Diversity across CRISPR-Cas Systems
Leenay, R. T., Maksimchuk, K. R., Slotkowski, R. A., Agrawal, R. N., Gomaa, A. A., Briner, A. E., Barrangou, R., & Beisel, C. L. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.031 · Cited by 336
Complex transcriptional modulation with orthogonal and inducible dCas9 regulators
Gao, Y., Xiong, X., Wong, S., Charles, E. J., Lim, W. A., & Qi, L. S. (2016) · Nature Methods · doi:10.1038/nmeth.4042 · Cited by 329
Ranjha, L., Howard, S. M., & Cejka, P. (2018) · Chromosoma · doi:10.1007/s00412-017-0658-1 · Cited by 325
Zischewski, J., Fischer, R., & Bortesi, L. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.12.003 · Cited by 323
Kimura, Y., Hisano, Y., Kawahara, A., & Higashijima, S.-I. (2014) · Scientific Reports · doi:10.1038/srep06545 · Cited by 326
CRISPR–Cas systems: beyond adaptive immunity
Westra, E. R., Buckling, A., & Fineran, P. C. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3241 · Cited by 323
Hillary, V. E., & Ceasar, S. A. (2023) · Molecular Biotechnology · doi:10.1007/s12033-022-00567-0 · Cited by 320
“The type II locus encodes multidomain protein to target and cleave the dsDNA [8].”
BackgroundCRISPR Ethics: Moral Considerations for Applications of a Powerful Tool
Brokowski, C., & Adli, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.044 · Cited by 320
CRISPR/Cas9 genome editing in human hematopoietic stem cells.
Bak, R. O., Dever, D. P., & Porteus, M. H. (2018) · Nature Protocols · doi:10.1038/nprot.2017.143 · Cited by 319
Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne’s Muscular Dystrophy
Lek, A., Wong, B., Keeler, A., Blackwood, M., Ma, K., Huang, S., Sylvia, K., Batista, A. R., Artinian, R., Kokoski, D., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307798 · Cited by 319
Genome‐scale engineering for systems and synthetic biology
Esvelt, K. M., & Wang, H. H. (2013) · Molecular Systems Biology · doi:10.1038/msb.2012.66 · Cited by 320
Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities
Liu, L., Li, X., Wang, J., Wang, M., Chen, P., Yin, M., Li, J., Sheng, G., & Wang, Y. (2017) · Cell · doi:10.1016/j.cell.2016.12.031 · Cited by 328
Towards CRISPR/Cas crops – bringing together genomics and genome editing
Scheben, A., Wolter, F., Batley, J., Puchta, H., & Edwards, D. (2017) · New Phytologist · doi:10.1111/nph.14702 · Cited by 313
Zeng, Y., Wen, J., Zhao, W., Wang, Q., & Huang, W. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2019.01663 · Cited by 311
Fate and state of vascular smooth muscle cells in atherosclerosis
Miano, J. M., Fisher, E. A., & Majesky, M. W. (2021) · Circulation · doi:10.1161/circulationaha.120.049922 · Cited by 318
Thrips transmission of tospoviruses
Rotenberg, D., Jacobson, A. L., Schneweis, D. J., & Whitfield, A. E. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.08.003 · Cited by 310
“Advancements in CRISPR/Cas9 technology may provide a functional tool for future genome editing in thrips [82,83].”
MethodCRISPR-Based Methods for Caenorhabditis elegans Genome Engineering
Dickinson, D. J., & Goldstein, B. (2016) · Genetics · doi:10.1534/genetics.115.182162 · Cited by 332
Regulation and safety measures for nanotechnology-based agri-products
Kumari, R., Suman, K., Karmakar, S., Mishra, V., Lakra, S. G., Saurav, G. K., & Mahto, B. K. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1200987 · Cited by 298
“The constraints of designing an ideal NC with a broad host range, high cargo loading capacity, and efficiency are thus the subject of great attention, to access plant cells and the potential to move inside a plant’s system without the need for external mechanical aid (Jinek et al., 2012; Burlaka et al., 2015; Cunningh…”
BackgroundGenetic Engineering for Disease Resistance in Plants: Recent Progress and Future Perspectives
Dong, O. X., & Ronald, P. C. (2019) · Plant Physiology · doi:10.1104/pp.18.01224 · Cited by 309
“Besides SpCas9, other Cas family nucleases that require different PAM sequences have been identified or developed (Wu et al., 2018).”
BackgroundInfluentialUniversal CARs, universal T cells, and universal CAR T cells
Zhao, J., Lin, Q., Song, Y., & Liu, D. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0677-2 · Cited by 310
Multiplexable, locus-specific targeting of long RNAs with CRISPR-Display
Shechner, D. M., Hacisuleyman, E., Younger, S. T., & Rinn, J. L. (2015) · Nature Methods · doi:10.1038/nmeth.3433 · Cited by 316
A decade of discovery: CRISPR functions and applications
Barrangou, R., & Horvath, P. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.92 · Cited by 319
Feng, W., Newbigging, A. M., Tao, J., Cao, Y., Peng, H., Le, C., Wu, J., Pang, B., Li, J., Tyrrell, D. L., et al. (2021) · Chemical Science · doi:10.1039/d0sc06973f · Cited by 312
CRISPRTarget: Bioinformatic prediction and analysis of crRNA targets
Biswas, A., Gagnon, J. N., Brouns, S. J. J., Fineran, P. C., & Brown, C. M. (2013) · RNA Biology · doi:10.4161/rna.24046 · Cited by 318
“20,22,23 Typically, organisms have several CRISPR arrays containing a range of spacers with different sequences derived from previous exposure to phages and plasmids.”
BackgroundJia, H., Orbovic, V., Jones, J. B., & Wang, N. (2016) · Plant Biotechnology Journal · doi:10.1111/pbi.12495 · Cited by 309
CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
Su, S., Hu, B., Shao, J., Shen, B., Du, J., Du, Y., Zhou, J., Yu, L., Zhang, L., Chen, F., et al. (2016) · Scientific Reports · doi:10.1038/srep20070 · Cited by 305
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
Monteys, A. M., Ebanks, S. A., Keiser, M. S., & Davidson, B. L. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.010 · Cited by 309
“Targeting specificity of the CRISPR/Cas9 complex is regulated by two different elements, first, the binding complementarity between the targeted genomic DNA sequence (genDNA) and the 20 nt-guiding sequence of the sgRNA, and, second, the presence of a protospacer-adjacent motif (PAM) juxtaposed to the genDNA/sgRNA comp…”
CRISPR/Cas9‐mediated targeted mutagenesis of GmFT2a delays flowering time in soya bean
Cai, Y., Chen, L., Liu, X., Guo, C., Sun, S., Wu, C., Jiang, B., Han, T., & Hou, W. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12758 · Cited by 309
“The Cas9 protein can form a complex with a synthetic sgRNA, which guides it to recognize target sequences and generate double-strand breaks (DSBs) at expected target sites (Jinek et al. , 2012).”
Targeted genomic rearrangements using CRISPR/Cas technology
Choi, P. S., & Meyerson, M. (2014) · Nature Communications · doi:10.1038/ncomms4728 · Cited by 309
Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action
Riching, K. M., Mahan, S., Corona, C. R., McDougall, M., Vasta, J. D., Robers, M. B., Urh, M., & Daniels, D. L. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00692 · Cited by 304
DNA hydrogel-based gene editing and drug delivery systems
Mo, F., Jiang, K., Zhao, D., Wang, Y., Song, J., & Tan, W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.018 · Cited by 304
Ren, X., Yang, Z., Xu, J., Sun, J., Mao, D., Hu, Y., Yang, S.-J., Qiao, H.-H., Wang, X., Hu, Q., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.044 · Cited by 309
Fister, A. S., Landherr, L., Maximova, S. N., & Guiltinan, M. J. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.00268 · Cited by 297
“After development of the CRISPR/Cas9 strategy as a tool for targeted genome editing (Jinek et al., 2012), it quickly became a powerful resource for crop improvement (Miao et al., 2013; Schaeffer and Nakata, 2015; Petolino et al., 2016).”
MethodTang, X., Liu, G., Zhou, J., Ren, Q., You, Q., Tian, L., Xin, X., Zhong, Z., Liu, B., Zheng, X., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1458-5 · Cited by 306
“However, Cas9 may cause undesired off-target mutations due to sgRNAs recognizing DNA sequences with one to a few nucleotide mismatches, albeit with reduced nuclease binding and cleavage activity [1, 6, 17, 18].”
BackgroundMethods for Optimizing CRISPR-Cas9 Genome Editing Specificity
Tycko, J., Myer, V. E., & Hsu, P. D. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.07.004 · Cited by 305
“…adaptive immune systems known asCRISPR-Cas (Mojica et al., 2000, 2005; Jansen et al., 2002; Pourcel et al., 2005; Barrangou et al., 2007), the Cas9 nuclease can localize and cleave a target DNA via a guide RNA (Brouns et al., 2008; Deltcheva et al., 2011; Gasiunas et al., 2012; Jinek et al., 2012).”
BackgroundA Mouse Geneticist’s Practical Guide to CRISPR Applications
Singh, P., Schimenti, J. C., & Bolcun-Filas, E. (2015) · Genetics · doi:10.1534/genetics.114.169771 · Cited by 305
CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome
Shin, H. Y., Wang, C., Lee, H. K., Yoo, K. H., Zeng, X., Kuhns, T., Yang, C. M., Mohr, T., Liu, C., & Hennighausen, L. (2017) · Nature Communications · doi:10.1038/ncomms15464 · Cited by 309
Sundin, G. W., Castiblanco, L. F., Yuan, X., Zeng, Q., & Yang, C. (2016) · Molecular Plant Pathology · doi:10.1111/mpp.12436 · Cited by 299
“nucleotides, was then demonstrated to be functional for the introduction of genome modifications with precise target-specificity (Jinek et al., 2012).”
CRISPR/Cas9-mediated efficient targeted mutagenesis in Chardonnay (Vitis vinifera L.)
Ren, C., Liu, X., Zhang, Z., Wang, Y., Duan, W., Li, S., & Liang, Z. (2016) · Scientific Reports · doi:10.1038/srep32289 · Cited by 300
Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1
Yamano, T., Zetsche, B., Ishitani, R., Zhang, F., Nishimasu, H., & Nureki, O. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.035 · Cited by 322
“Second, Cpf1 recognizes a T-rich PAM (Zetsche et al., 2015), whereas Cas9 favors a G-rich PAM (Jinek et al., 2012; Fonfara et al., 2014; Karvelis et al., 2015; Ran et al., 2015).”
BackgroundRekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Kim, B., Park, J., & Sailor, M. J. (2019) · Advanced Materials · doi:10.1002/adma.201903637 · Cited by 298
Somatic mosaicism and allele complexity induced by CRISPR/Cas9 RNA injections in mouse zygotes
Yen, S.-T., Zhang, M., Deng, J. M., Usman, S. J., Smith, C. N., Parker-Thornburg, J., Swinton, P. G., Martin, J. F., & Behringer, R. R. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.06.017 · Cited by 300
“The sgRNA is a chimeric molecule, containing the CRISPR RNA (crRNA) and the transacting RNA (tracrRNA) (Jinek et al., 2012).”
CRISPR/Cas9-based engineering of the epigenome
Pulecio, J., Verma, N., Mejía-Ramírez, E., Huangfu, D., & Raya, A. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.09.006 · Cited by 300
“A major breakthrough came from the advent of the CRISPR/Cas9 system, in which the Cas9 endonuclease can be targeted to specific DNA sequences by guide RNAs (gRNAs) that are easily programma- ble (Jinek et al., 2012).”
A Cas9-based toolkit to program gene expression in Saccharomyces cerevisiae
Reider Apel, A., d'Espaux, L., Wehrs, M., Sachs, D., Li, R. A., Tong, G. J., Garber, M., Nnadi, O., Zhuang, W., Hillson, N. J., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1023 · Cited by 306
Recent progress in non-native nucleic acid modifications
McKenzie, L. K., El-Khoury, R., Thorpe, J. D., Damha, M. J., & Hollenstein, M. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01430c · Cited by 300
Taylor, M. J., Lukowski, J. K., & Anderton, C. R. (2021) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.0c00439 · Cited by 302
The CRISPR/Cas System mediates efficient genome engineering in Bombyx mori
Wang, Y., Li, Z., Xu, J., Zeng, B., Ling, L., You, L., Chen, Y., Huang, Y., & Tan, A. (2013) · Cell Research · doi:10.1038/cr.2013.146 · Cited by 300
Zhou, X., Jacobs, T. B., Xue, L., Harding, S. A., & Tsai, C. (2015) · New Phytologist · doi:10.1111/nph.13470 · Cited by 301
One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces
Huang, H., Zheng, G., Jiang, W., Hu, H., & Lu, Y. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv007 · Cited by 289
Applying CRISPR/Cas for genome engineering in plants: the best is yet to come
Puchta, H. (2017) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2016.11.011 · Cited by 297
Gaussian accelerated molecular dynamics: Principles and applications
Wang, J., Arantes, P. R., Bhattarai, A., Hsu, R. V., Pawnikar, S., Huang, Y. M., Palermo, G., & Miao, Y. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1521 · Cited by 295
Chen, Z., Liu, F., Chen, Y., Liu, J., Wang, X., Chen, A. T., Deng, G., Zhang, H., Liu, J., Hong, Z., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703036 · Cited by 297
Efficient targeted mutagenesis of rice and tobacco genomes using Cpf1 from Francisella novicida
Endo, A., Masafumi, M., Kaya, H., & Toki, S. (2016) · Scientific Reports · doi:10.1038/srep38169 · Cited by 299
Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice
Aida, T., Chiyo, K., Usami, T., Ishikubo, H., Imahashi, R., Wada, Y., Tanaka, K. F., Sakuma, T., Yamamoto, T., & Tanaka, K. (2015) · Genome Biology · doi:10.1186/s13059-015-0653-x · Cited by 296
“We developed a cell-free in vitro digestion assay (IDA) system [13] using the target Actb PCR product, Cas9 protein, and chemically synthesized dual RNAs (Figure 3a).”
BackgroundMethodInfluentialPost-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair
Gutschner, T., Haemmerle, M., Genovese, G., Draetta, G. F., & Chin, L. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.019 · Cited by 299
Renaud, J.-B., Boix, C., Charpentier, M., De Cian, A., Cochennec, J., Duvernois-Berthet, E., Perrouault, L., Tesson, L., Edouard, J., Thinard, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.018 · Cited by 301
“Poor efficiency of precise insertion could be due to insufficient levels of available complementary ‘‘acceptor’’ ends after target sequence cleavage by Cas9, which is known to generate blunt ends (Jinek et al., 2012).”
BackgroundA review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer
Jain, V., Kumar, H., Anod, H. V., Chand, P., Gupta, N. V., Dey, S., & Kesharwani, S. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.003 · Cited by 290
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
Xu, X., Liu, C., Wang, Y., Koivisto, O., Zhou, J., Shu, Y., & Zhang, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113891 · Cited by 289
Wang, P., Zhang, J., Sun, L., Ma, Y., Xu, J., Liang, S., Deng, J., Tan, J., Zhang, Q., Tu, L., et al. (2018) · Plant Biotechnology Journal · doi:10.1111/pbi.12755 · Cited by 289
“It requires a crRNA and a tracRNA to form the two-RNA structure, which is later integrated within one transcript and termed as sgRNA, to guide the Cas9 endonucleases to the target DNA sequences (Jinek et al., 2012).”
BackgroundMetabolic engineering advances and prospects for amino acid production
Wendisch, V. F. (2020) · Metabolic Engineering · doi:10.1016/j.ymben.2019.03.008 · Cited by 294
Nidhi, S., Anand, U., Oleksak, P., Tripathi, P., Lal, J. A., Thomas, G., Kuca, K., & Tripathi, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073327 · Cited by 276
“The development of the RNA-programmable site-specific CRISPR–Cas9 system in gene editing methods published in the Science journal [27] inspired countless potential applications and won many internationally acclaimed awards including a Nobel Prize.”
MethodSomatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
Zuckermann, M., Hovestadt, V., Knobbe-Thomsen, C. B., Zapatka, M., Northcott, P. A., Schramm, K., Belic, J., Jones, D. T. W., Tschida, B., Moriarity, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms8391 · Cited by 283
A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9
Dagdas, Y. S., Chen, J. S., Sternberg, S. H., Doudna, J. A., & Yildiz, A. (2017) · Science Advances · doi:10.1126/sciadv.aao0027 · Cited by 293
“DNA cleavage activity ofCas9 requiresMg at the catalytic site (6), yet it remains stably bound Active Inactive”
BackgroundInfluentialSelf-citationMukama, O., Wu, J., Li, Z., Liang, Q., Yi, Z., Lu, X., Liu, Y., Liu, Y., Hussain, M., Makafe, G. G., et al. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112143 · Cited by 288
Laughery, M. F., Hunter, T., Brown, A., Hoopes, J., Ostbye, T., Shumaker, T., & Wyrick, J. J. (2015) · Yeast · doi:10.1002/yea.3098 · Cited by 306
“…key advance was the discovery that a hybrid ’single guide’ RNA (sgRNA) that fuses the crRNA guide sequence to the tracrRNA can be used for efficient Cas9 targeting (Jinek et al., 2012) in a plethora of different organisms (Doudna and Charpentier, 2014; Hsu et al., 2014; Sternberg and Doudna, 2015).”
BackgroundMethodInfluentialPrecise and efficient genome editing in zebrafish using the CRISPR/Cas9 system
Irion, U., Krauss, J., & Nüsslein-Volhard, C. (2014) · Development · doi:10.1242/dev.115584 · Cited by 289
Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity
Charpentier, E., Richter, H., van der Oost, J., & White, M. F. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv023 · Cited by 289
Self-citation
Metadata
- Authors
- Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (HHMI), University of California, Berkeley, CA 94720, USA.
- University of Vienna (AT)
- Umeå Centre for Microbial Research (SE)
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Chylinski, Krzysztof
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2012-08-17
- Volume
- 337
- Issue
- 6096
- Pages
- 816-821
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6286148
- OpenAlex
- W2045435533
- Semantic Scholar
- 68d962effe5520777791bd6ec8ffa4b963ba4f38
- Cited by
- 17,116
- References
- 48
- Citations by year
- 2026: 1083 · 2025: 1512 · 2024: 1602 · 2023: 1572 · 2022: 1795 · 2021: 1793 · 2020: 1577 · 2019: 1344 · 2018: 1255 · 2017: 1141 · 2016: 1018 · 2015: 680 · 2014: 467 · 2013: 231 · 2012: 29
- FWCI
- 180.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, sequence-specific DNA cleavage, DNA double-strand breaks
- MeSH terms
- Bacteriophages, Base Sequence, Molecular Sequence Data, Nucleic Acid Conformation, Plasmids, RNA, Streptococcus pyogenes, Deoxyribonucleases, Type II Site-Specific, DNA Cleavage, DNA Breaks, Double-Stranded, Inverted Repeat Sequences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.